| UK AGM, EGM Calendar |
| Monday, April 25 |
| Hammerson |
| Biome Technologies |
| Minoan Group |
| Sterling Energy |
| TBC Bank |
| Tuesday, April 26 |
| Harworth Group |
| Dialight |
| EMIS Group |
| Modern Water |
| Murray International Trust |
| Foreign & Colonial Investment Trust |
| STV Group |
| Polar Capital Global Financials Trust |
| Jardine Lloyd Thompson Group |
| RPS Group |
| Equiniti Group |
| Wednesday, April 27 |
| Just Eat |
| British American Tobacco |
| Amec Foster Wheeler |
| Countrywide |
| Hutchison China MediTech |
| Glanbia |
| Genel Energy |
| Dalata Hotel Group |
| Matomy Media Group (re additonal payment to chairman) |
| Greencoat UK Wind |
| Symphony International Holdings |
| Kennedy Wilson Europe Real Estate |
| Croda International |
| Elementis |
| Mithras Investment Trust |
| Devro |
| Fidessa Group |
| London Stock Exchange Group |
| JPMorgan US Smaller Co IT |
| Thursday, April 28 |
| ARM Holdings |
| CRH |
| Admiral Group |
| Barclays |
| Taylor Wimpey |
| Tullow Oil |
| Synthomer |
| Gresham Computing |
| SpaceandPeople |
| AFC Energy |
| Sphere Medical Holding |
| Aggreko |
| Witan Investment Trust |
| Manx Financial Group |
| Berendsen |
| FDM Group |
| LSL Property Services |
| Capital Drilling |
| Cobham |
| Aberdeem UK Tracker |
| Pendragon |
| Servelec Group |
| Bank of Ireland |
| Schroders |
| Henderson High Income Trust |
| Shires Income |
| James Fisher & Sons |
| SDL |
| Friday, April 29 |
| AstraZeneca |
| Pearson |
| Laird |
| Rotork |
| Asian Total Return Investment Company |
| One Media IP Group |
| GLI Finance |
| Caza Oil & Gas (re delisting) |
| Ultra Electronics Holdings |
| BlackRock Latin American Investment Trust |
| Copyright 2016 Alliance News Limited. All Rights Reserved. |
Astrazeneca (AZN)
Pearson (PSON)
Schroder Asian (ATR)
Blackrock Lat A (BRLA)
Rotork (ROR)
One Media (OMIP)18 Jun 2024 09:33
TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results
(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.
